Equities research analysts at StockNews.com began coverage on shares of LiqTech International (NASDAQ:LIQT – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock.
Several other brokerages have also weighed in on LIQT. Lake Street Capital lowered their target price on shares of LiqTech International from $9.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. Ascendiant Capital Markets lowered their price objective on shares of LiqTech International from $5.15 to $3.20 and set a “buy” rating for the company in a research report on Monday.
Check Out Our Latest Stock Analysis on LiqTech International
LiqTech International Price Performance
Hedge Funds Weigh In On LiqTech International
An institutional investor recently raised its position in LiqTech International stock. HighTower Advisors LLC grew its holdings in LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,599 shares of the company’s stock after purchasing an additional 11,043 shares during the quarter. HighTower Advisors LLC owned 0.66% of LiqTech International worth $99,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 35.06% of the company’s stock.
About LiqTech International
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Recommended Stories
- Five stocks we like better than LiqTech International
- Health Care Stocks Explained: Why You Might Want to Invest
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Quiet Period Expirations Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is Short Interest? How to Use It
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.